Mike, just do a control F and search for chronic. It is under the revenue recognition. In all actuality, the author of the article that Pharmaman commented on actually had the same words in his article, if you take the time to read it.
In all actuality, I am sure he does pretty good in the market. His research is so bad, I can't believe that he is really that dumb. He has to be using his reputation to game the system. Obtain a large short position, write a trash article and then cover. He uses every bit of his waiver "Citron does not guarantee in any way that it is providing all of the information that may be available. We recommend that you do your own due diligence before buying or selling any security. At any times the principals of Citron might hold a position in any of the securities profiled on the site. Citron will not report when a position is initiated or covered. Each investor must make that decision based on his/her judgment of the market." direct from his site
It is actually kind of funny. The story is so bad it is ridiculous. I decided to take 5 minutes and I clicked on the seeking alpha link that Citron referenced in their story. The story is from 10/23/2013. Then I went to Questcor's 10Q filed in July. The specific language that citron says Pharmaman knew on 10/23/2013 was used by QCOR in their July 10Q. Wow that was too easy. You can verify it yourself in less than 5 minutes. But wait, that is right you don't actually want to know the truth
Johnny, I was thinking the same thing myself. Even the volume was relatively muted from the attacks from last year. I remember the day it took the major collaspe, there was something like 60 million shares trading hands (it was more than the entire float of the company). Yesterday, there were only 10 million shares. I really liked the quarter. Hard to believe the company is only selling at 3.5X sales with the margins that they have.